Nucleic Acid Therapeutics Journal Issues Research Articles in February 2022 Edition
February 03, 2022
February 03, 2022
NEW ROCHELLE, New York, Feb. 3 -- Nucleic Acid Therapeutics, a peer-reviewed journal that says it features nucleic acids and related compounds to alter gene expression for therapeutic purposes, published research articles on the following topics in its February 2022 edition:
Review:
* CRISPR/Cas and Hepatitis B Therapy: Technological Advances and Practical Barriers
Original Papers:
* Long-Term Safety and Efficacy Data of Golodirsen in Ambulat . . .
Review:
* CRISPR/Cas and Hepatitis B Therapy: Technological Advances and Practical Barriers
Original Papers:
* Long-Term Safety and Efficacy Data of Golodirsen in Ambulat . . .
